Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (ACRS)

Q4 2022 13F Holders as of 12/31/2022

Type / Class
Equity / Common Stock, $0.00001 par value
Number of holders
125
Total Shares
65.8M
Shares change
-160K
Total reported value, excl. options
$1.04B
Value change
-$2.52M
Put/Call ratio
1.11
Number of buys
56
Number of sells
-44
Price
$15.75
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.